Automated 68Ga-PSMA-PET Total Metabolic Tumor Volume (TMTV) extraction for predicting PSA change in 177Lu-PSMA therapy

被引：0
作者：
Eduardo, R. [1 ,2 ]
David, S. [1 ]
Noel, B. Jean [1 ]
机构：
[1] Creatis, Lyon, France
[2] Siemens Healthcare, Paris, France
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2024年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EPS-110
引用
收藏
页码：S179 / S180
页数：2
相关论文
共 50 条
  • [21] Deep learning for 177Lu-PSMA dose prediction from pre-therapeutic 68Ga-PSMA PET/CT radiomics features
    Balaji, Vibha
    Yang, Fan
    Lei, Bowen
    Luo, Jie
    Heidari, Pedram
    Li, Quanzheng
    Dutta, Joyita
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [22] Extension of a 68Ga-PSMA PET-based nomogram for outcome prediction of 177Lu-PSMA radioligand therapy for the use of 18F-rhPSMA-7.3
    Rauscher, I.
    Hansen, K.
    Gafita, A.
    Weber, W. A.
    Eiber, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S327 - S327
  • [23] Response assessment using 68Ga-PSMA ligand PET in patients undergoing 177Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer
    Bernhard Grubmüller
    Daniela Senn
    Gero Kramer
    Pascal Baltzer
    David D’Andrea
    Karl Hermann Grubmüller
    Markus Mitterhauser
    Harald Eidherr
    Alexander R. Haug
    Wolfgang Wadsak
    Sarah Pfaff
    Shahrokh F. Shariat
    Marcus Hacker
    Markus Hartenbach
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 1063 - 1072
  • [24] Pretherapeutic 68Ga-PSMA-617 PET May Indicate the Dosimetry of 177Lu-PSMA-617 and 177Lu-EB-PSMA-617 in Main Organs and Tumor Lesions
    Wang, Jingnan
    Zang, Jie
    Wang, Hao
    Liu, Qingxing
    Li, Fang
    Lin, Yansong
    Huo, Li
    Jacobson, Orit
    Niu, Gang
    Fan, Xinrong
    Zhu, Zhaohui
    Chen, Xiaoyuan
    [J]. CLINICAL NUCLEAR MEDICINE, 2019, 44 (06) : 431 - 438
  • [25] Response assessment using 68Ga-PSMA ligand PET in patients undergoing 177Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer
    Grubmueller, Bernhard
    Senn, Daniela
    Kramer, Gero
    Baltzer, Pascal
    D'Andrea, David
    Grubmueller, Karl Hermann
    Mitterhauser, Markus
    Eidherr, Harald
    Haug, Alexander R.
    Wadsak, Wolfgang
    Pfaff, Sarah
    Shariat, Shahrokh F.
    Hacker, Marcus
    Hartenbach, Markus
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (05) : 1063 - 1072
  • [26] Investigation of [177Lu]Lu-PSMA-617 therapy minimum cycle interval with [68Ga]Ga-PSMA-11 PET/CT
    Costa, G.
    Yousefzadeh-Nowshahr, E.
    Orlov, C.
    Fitzpatrick, K.
    Frey, K.
    Beer, A.
    Dewaraja, Y.
    Glatting, G.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S210 - S210
  • [27] Baseline [68Ga]Ga-PSMA-11 PET/CT before [177Lu]Lu-PSMA-617 Radioligand Therapy: Value of PSMA-Uptake Thresholds in Predicting Targetable Lesions
    Groener, Daniel
    Schneider, Sina
    Baumgarten, Justus
    Happel, Christian
    Klimek, Konrad
    Mader, Nicolai
    Ngoc, Christina Nguyen
    Wichert, Jennifer
    Mandel, Philipp
    Tselis, Nikolaos
    Gruenwald, Frank
    Sabet, Amir
    [J]. CANCERS, 2023, 15 (02)
  • [28] Predictive and prognostic potential of pretreatment 68Ga-PSMA PET tumor heterogeneity index in patients with metastatic castration-resistant prostate cancer treated with 177Lu-PSMA
    Assadi, Majid
    Manafi-Farid, Reyhaneh
    Jafari, Esmail
    Keshavarz, Ahmad
    Divband, GhasemAli
    Moradi, Mohammad Mobin
    Adinehpour, Zohreh
    Samimi, Rezvan
    Dadgar, Habibollah
    Jokar, Narges
    Mayer, Benjamin
    Prasad, Vikas
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [29] [68Ga]Ga-PSMA PET/MRI, histological PSMA expression and preliminary experience with [177Lu]Lu-PSMA therapy in relapsing high-grade glioma
    Truckenmueller, Peter
    Graef, Josefine
    Scheel, Michael
    Vajkoczy, Peter
    Capper, David
    Kaul, David
    Furth, Christian
    Amthauer, Holger
    Brenner, Winfried
    Onken, Julia Sophie
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [30] Estimating 177Lu-PSMA Radiopharmaceutical Therapy Tumor Dosimetry from PET: Implications for Improving Treatment Response
    Hesterman, Jacob
    Orcutt, Kelly
    Hoppin, Jack
    Kuo, Phillip
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2023, 64
12345